Friday, February 4, 2022

< + > Regeneron Expects Zero Covid Antibody Sales For The First Quarter Of 2022

The company’s antibody therapy has been determined to be ineffective against the omicron variant that now dominates Covid-19 cases worldwide.

No comments:

Post a Comment

< + > Proofpoint’s Intelligent Monitoring Catches Both Accidental and Malicious Email Breaches

Proofpoint understands that data breaches can take place through outgoing as well as incoming communications, and through a wide variety of...